Staar Surgical Co Share Price (NASDAQ: STAA)

$28.39

▲

-0.18

(-0.63%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Staar Surgical Co Stock chart to analyse performance

Staar Surgical Co stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$28.35
Today's High:$28.91
$28.39
0.16%
Downside
Day's Volatility :1.95%
Upside
1.8%
52 Weeks Low:$13.50
52 Weeks High:$38.60
$28.39
52.45%
Downside
52 Weeks Volatility :65.03%
Upside
26.45%

Staar Surgical Co Stock Returns

Period	Staar Surgical Co	Sector (Health Care)	Index (Russel 2000)
3 Months	47.74%	2.3%	0.0%
6 Months	71.02%	-5.9%	0.0%
1 Year	-25.72%	-10.9%	0.0%
3 Years	-71.7%	2.3%	-11.0%

Staar Surgical Co Key Stats

Check Staar Surgical Co key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$28.57
Open	$28.65
Today's High	$28.91
Today's Low	$28.345
Market Capitalization	$1.4B
Today's Volume	$1.2M
52 Week High	$38.6
52 Week Low	$13.5
Revenue TTM	$224.4M
EBITDA	$-73.0M
Earnings Per Share (EPS)	$-1.93
Profit Margin	-42.45%
Quarterly Earnings Growth YOY	1.02%
Return On Equity TTM	-25.55%

Stock Returns calculator for Staar Surgical Co Stock including INR - Dollar returns

The Staar Surgical Co stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Staar Surgical Co investment value today

Current value as on today

₹78,355

Returns

₹21,645

(-21.65%)

Returns from Staar Surgical Co Stock

₹25,855 (-25.86%)

Dollar Returns*

₹4,210 (+4.21%)

Indian investors sentiment towards Staar Surgical Co Stock

288%

Period: Jul 17, 2025 to Aug 16, 2025. Change in 30 Days versus previous period

Search interest for Staar Surgical Co Stock from India on INDmoney has increased by 288% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Staar Surgical Co

Name
Holdings %
Name
Holdings %
BROADWOOD CAPITAL Inc
25.14%
BlackRock Inc
15.64%
Vanguard Group Inc
10.93%
Armistice Capital, LLC
6.05%
Soleus Capital Management, L.P.
5.17%
Resona Asset Management Co., Ltd.
4.38%

Analyst Recommendation on Staar Surgical Co Stock

Rating

Trend

Buy

63%Buy

36%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Staar Surgical Co(by analysts ranked 0 to 5 stars)

Staar Surgical Co Share Price Target

What analysts predicted

Downside of 14.96%

Target:

$24.14

Current:

$28.39

Staar Surgical Co share price target is $24.14, a slight Downside of 14.96% compared to current price of $28.39 as per analysts' prediction.

Staar Surgical Co Stock Insights

Price Movement
In the last 1 month, STAA stock has moved up by 64.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 42.58M → 44.32M (in $), with an average increase of 3.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -54.21M → -16.81M (in $), with an average increase of 222.5% per quarter
STAA vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 25.2% return, outperforming this stock by 50.2%
STAA vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 20.6% return, outperforming this stock by 92.3%
Price to Sales
ForSTAA every $1 of sales, investors are willing to pay $6.3, whereas for Resmed Inc., the investors are paying $8.1 for every $1 of sales.

Staar Surgical Co Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY22

FY23

FY24

	FY22	Y/Y Change
Revenue	$284.4M	↑ 23.4%
Net Income	$39.7M	↑ 44.18%
Net Profit Margin	13.95%	↑ 2.01%

	FY22	Y/Y Change
Revenue	$284.4M	↑ 23.4%
Net Income	$39.7M	↑ 44.18%
Net Profit Margin	13.95%	↑ 2.01%

	FY23	Y/Y Change
Revenue	$322.4M	↑ 13.37%
Net Income	$21.3M	↓ 46.18%
Net Profit Margin	6.62%	↓ 7.33%

	FY23	Y/Y Change
Revenue	$322.4M	↑ 13.37%
Net Income	$21.3M	↓ 46.18%
Net Profit Margin	6.62%	↓ 7.33%

	FY24	Y/Y Change
Revenue	$313.9M	↓ 2.64%
Net Income	$-20.2M	↓ 194.66%
Net Profit Margin	-6.44%	↓ 13.06%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q2 FY24	Q/Q Change
Revenue	$99.0M	↑ 27.99%
Net Income	$7.4M	↓ 320.99%
Net Profit Margin	7.45%	↑ 11.77%

	Q2 FY24	Q/Q Change
Revenue	$99.0M	↑ 27.99%
Net Income	$7.4M	↓ 320.99%
Net Profit Margin	7.45%	↑ 11.77%

	Q3 FY24	Q/Q Change
Revenue	$88.6M	↓ 10.52%
Net Income	$10.0M	↑ 35.25%
Net Profit Margin	11.27%	↑ 3.82%

	Q4 FY24	Q/Q Change
Revenue	$49.0M	↓ 44.75%
Net Income	$-34.2M	↓ 442.97%
Net Profit Margin	-69.92%	↓ 81.19%

	Q1 FY25	Q/Q Change
Revenue	$42.6M	↓ 12.99%
Net Income	$-54.2M	↑ 58.38%
Net Profit Margin	-127.29%	↓ 57.37%

	Q2 FY25	Q/Q Change
Revenue	$44.3M	↑ 4.06%
Net Income	$-16.8M	↓ 68.99%
Net Profit Margin	-37.93%	↑ 89.36%

FY22

FY23

FY24

	FY22	Y/Y Change
Profit	$223.4M	-

	FY23	Y/Y Change
Profit	$252.7M	-

	FY24	Y/Y Change
Profit	$239.6M	-

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q2 FY24	Q/Q Change
Profit	$78.4M	-

	Q3 FY24	Q/Q Change
Profit	$68.5M	↓ 12.66%

	Q4 FY24	Q/Q Change
Profit	$31.6M	↓ 53.79%

	Q1 FY25	Q/Q Change
Profit	$28.0M	↓ 11.51%

	Q2 FY25	Q/Q Change
Profit	$32.8M	↑ 17.12%

FY22

FY23

FY24

	FY22	Y/Y Change
Operating Cash Flow	$35.7M	↓ 18.76%
Investing Cash Flow	$-156.4M	↑ 1046.03%
Financing Cash Flow	$8.3M	↓ 53.37%

	FY22	Y/Y Change
Operating Cash Flow	$35.7M	↓ 18.76%
Investing Cash Flow	$-156.4M	↑ 1046.03%
Financing Cash Flow	$8.3M	↓ 53.37%

	FY23	Y/Y Change
Operating Cash Flow	$14.6M	↓ 59.14%
Investing Cash Flow	$74.3M	↓ 147.54%
Financing Cash Flow	$7.4M	↓ 10.63%

	FY23	Y/Y Change
Operating Cash Flow	$14.6M	↓ 59.14%
Investing Cash Flow	$74.3M	↓ 147.54%
Financing Cash Flow	$7.4M	↓ 10.63%

	FY24	Y/Y Change
Operating Cash Flow	$15.7M	↑ 7.75%
Investing Cash Flow	$-59.2M	-
Financing Cash Flow	$5.7M	↓ 22.81%

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-10.4M	↓ 148.03%
Investing Cash Flow	$-20.7M	-
Financing Cash Flow	$163.0K	↓ 95.98%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$3.8M	↓ 136.65%
Investing Cash Flow	$-35.2M	↑ 70.51%
Financing Cash Flow	$1.6M	↑ 890.8%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$642.0K	↓ 83.18%
Investing Cash Flow	$-19.5M	↓ 44.68%
Financing Cash Flow	$-110.0K	↓ 106.81%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-5.7M	↓ 993.15%
Investing Cash Flow	$35.4M	↓ 281.33%
Financing Cash Flow	$-948.0K	↑ 761.82%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-27.2M	↑ 375.22%
Investing Cash Flow	$25.1M	↓ 28.94%
Financing Cash Flow	$-4.5M	↑ 378.9%

Staar Surgical Co Technicals Summary

Sell

Neutral

Buy

Staar Surgical Co is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Staar Surgical Co Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Staar Surgical Co	63.82%	71.02%	-25.72%	-71.7%	-41.28%
Intuitive Surgical, Inc.	-7.42%	-20.1%	-0.42%	109.12%	108.03%
Alcon Ag	0.44%	-1.92%	-8.86%	27.27%	43.33%
West Pharmaceutical Services Inc	16.67%	16.6%	-18.45%	-23.54%	-10.63%
Resmed Inc.	10.57%	23.68%	23.3%	20.84%	55.82%
Becton, Dickinson And Company	9.57%	-12.95%	-16.93%	-25.69%	-25.73%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Staar Surgical Co	49.73	NA	-4.89	-0.85	-0.26	-0.11	NA	6.83
Intuitive Surgical, Inc.	66.69	66.69	3.51	8.12	0.16	0.09	NA	49.79
Alcon Ag	38.57	38.57	2.37	3.11	0.05	0.03	0.0	44.39
West Pharmaceutical Services Inc	36.91	36.91	3.56	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	29.94	29.94	1.92	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.65	35.65	0.98	14.35	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Staar Surgical Co	Buy	$1.4B	-41.28%	49.73	-42.45%
Intuitive Surgical, Inc.	Buy	$171.4B	108.03%	66.69	28.51%
Alcon Ag	Buy	$42.9B	43.33%	38.57	11.28%
West Pharmaceutical Services Inc	Buy	$17.7B	-10.63%	36.91	16.48%
Resmed Inc.	Buy	$41.7B	55.82%	29.94	27.22%
Becton, Dickinson And Company	Buy	$55.9B	-25.73%	35.65	7.41%

About Staar Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Organization	Staar Surgical Co
Employees	1157
CEO	Mr. Stephen C. Farrell CFA
Industry	Health Technology

Key Management of Staar Surgical Co

Name	Title
Mr. Stephen C. Farrell CFA	CEO & Director
Mr. Warren Foust	President & COO
Mr. Nathaniel B. Sisitsky Esq.	Senior VP, Chief Legal Officer, General Counsel & Corporate Secretary
Dr. Magda Michna Ph.D.	Chief Development Officer
Mr. Thomas G. Frinzi	Advisor
Ms. Deborah J. Andrews	Chief Financial Officer
Ms. Nancy Sabin	Chief Marketing Officer
Dr. Scott D. Barnes M.D.	Chief Medical Officer

Important FAQs about investing in STAA Stock from India :

What is Staar Surgical Co share price today?

Staar Surgical Co share price today is $28.39 as on August 16, 2025 at 1:29 AM IST at the close of the market. Staar Surgical Co share today touched a day high of $28.91 and a low of $28.35.

What is the 52 week high and 52 week low for Staar Surgical Co share?

Staar Surgical Co share touched a 52 week high of $38.60 and a 52 week low of $13.50. Staar Surgical Co stock price today, August 16, 2025 at 1:29 AM IST is trending at $28.39, lower by 26.45% versus the 52 week high.

How to invest in Staar Surgical Co Stock (STAA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Staar Surgical Co on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Staar Surgical Co Shares that will get you 0.0528 shares as per Staar Surgical Co share price of $28.39 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Staar Surgical Co Stock (STAA) from India?

Indian investors can start investing in Staar Surgical Co (STAA) shares with as little as ₹87.492 or $1 (as of August 17, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Staar Surgical Co stock (as per the Rupee-Dollar exchange rate as on August 17, 2025). Based on Staar Surgical Co share’s latest price of $28.39 as on August 16, 2025 at 1:29 AM IST, you will get 0.3522 shares of Staar Surgical Co. Learn more about fractional shares .

What are the returns that Staar Surgical Co has given to Indian investors in the last 5 years?

Staar Surgical Co stock has given -41.28% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?